v3.22.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]        
Revenues $ 127,173 $ 96,726 $ 321,000 $ 270,919
Operating expenses        
Cost of product sold 146,766 102,922 359,745 443,083
Selling, general and administrative expense 313,880 374,645 1,606,793 1,206,938
Total operating expenses 460,646 477,567 1,966,538 1,650,021
Loss from operations (333,473) (380,841) (1,645,538) (1,379,102)
Interest expense – bank debt 337 1,012
Interest expense - debt 21,661 53,410 26,570 248,940
Interest expense – financing cost 270,210
Amortization of debt discount 78,634 210,430 90,852 787,217
(Gain)/loss on extinguishment of debt upon notes conversion 56,729 55,278
Change in derivative liability 1,039,980 777,202
Other expense- non cash 168,887 15,192 204,391
Total other expense 100,295 1,529,773 402,824 2,074,040
Provision for income tax
Net Loss (433,768) (1,910,613) (2,048,362) (3,453,142)
Deemed dividend on Series B Stock 358,657
Net loss attributable to common shareholders $ (433,768) $ (1,910,613) $ (2,407,019) $ (3,453,142)
Basic and diluted net loss per common share (in Dollars per share) $ 0 $ (0.02) $ (0.03) $ (0.03)
Weighted average shares of capital outstanding – basic and diluted (in Shares) 89,725,839 74,194,855 90,899,831 68,091,616

Source